Retatrutide

A synthetic triple-agonist peptide investigated in preclinical metabolic research. Targets the GLP-1, GIP, and glucagon receptor pathways simultaneously. Studied for its role in energy metabolism, glucose regulation, and adipose tissue modulation.

This product is intended for research and laboratory purposes only. Not for human, animal, diagnostic, or household use. Customers are solely responsible for ensuring compliance with all applicable laws in their jurisdiction, including import regulations.